471 related articles for article (PubMed ID: 22498482)
1. HIV and viral hepatitis C coinfection in people who inject drugs: implications of new direct acting antivirals for hepatitis C virus treatment.
Walsh N; Maher L
Curr Opin HIV AIDS; 2012 Jul; 7(4):339-44. PubMed ID: 22498482
[TBL] [Abstract][Full Text] [Related]
2. Management of hepatitis C virus/HIV coinfection among people who use drugs in the era of direct-acting antiviral-based therapy.
Taylor LE; Swan T; Matthews GV
Clin Infect Dis; 2013 Aug; 57 Suppl 2(Suppl 2):S118-24. PubMed ID: 23884059
[TBL] [Abstract][Full Text] [Related]
3. Management of HCV and HIV infections among people who inject drugs.
Grebely J; Tyndall MW
Curr Opin HIV AIDS; 2011 Nov; 6(6):501-7. PubMed ID: 22001894
[TBL] [Abstract][Full Text] [Related]
4. HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject Drugs.
Martinello M; Hajarizadeh B; Grebely J; Dore GJ; Matthews GV
Curr HIV/AIDS Rep; 2017 Jun; 14(3):110-121. PubMed ID: 28432579
[TBL] [Abstract][Full Text] [Related]
5. Disparities in direct acting antivirals uptake in HIV-hepatitis C co-infected populations in Canada.
Saeed S; Strumpf EC; Moodie EE; Young J; Nitulescu R; Cox J; Wong A; Walmsely S; Cooper C; Vachon ML; Martel-Laferriere V; Hull M; Conway B; Klein MB;
J Int AIDS Soc; 2017 Nov; 20(3):. PubMed ID: 29116684
[TBL] [Abstract][Full Text] [Related]
6. Medical management of HIV-hepatitis C virus coinfection in injection drug users.
Khalsa JH; Kresina T; Sherman K; Vocci F
Clin Infect Dis; 2005 Jul; 41 Suppl 1():S1-6. PubMed ID: 16265605
[TBL] [Abstract][Full Text] [Related]
7. Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada.
Lanièce Delaunay C; Maheu-Giroux M; Marathe G; Saeed S; Martel-Laferrière V; Cooper CL; Walmsley S; Cox J; Wong A; Klein MB;
Int J Drug Policy; 2022 May; 103():103627. PubMed ID: 35218989
[TBL] [Abstract][Full Text] [Related]
8. Recommendations for the management of hepatitis C virus infection among people who inject drugs.
Robaeys G; Grebely J; Mauss S; Bruggmann P; Moussalli J; De Gottardi A; Swan T; Arain A; Kautz A; Stöver H; Wedemeyer H; Schaefer M; Taylor L; Backmund M; Dalgard O; Prins M; Dore GJ;
Clin Infect Dis; 2013 Aug; 57 Suppl 2():S129-37. PubMed ID: 23884061
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and correlates of HCV monoinfection and HIV and HCV coinfection among persons who inject drugs in Vietnam.
Zhang L; Celentano DD; Le Minh N; Latkin CA; Mehta SH; Frangakis C; Ha TV; Mo TT; Sripaipan T; Davis WW; Quan VM; Go VF
Eur J Gastroenterol Hepatol; 2015 May; 27(5):550-6. PubMed ID: 25769097
[TBL] [Abstract][Full Text] [Related]
10. Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study.
Solomon SS; Mehta SH; Srikrishnan AK; Solomon S; McFall AM; Laeyendecker O; Celentano DD; Iqbal SH; Anand S; Vasudevan CK; Saravanan S; Lucas GM; Kumar MS; Sulkowski MS; Quinn TC
Lancet Infect Dis; 2015 Jan; 15(1):36-45. PubMed ID: 25486851
[TBL] [Abstract][Full Text] [Related]
11. Coinfection with human immunodeficiency virus and hepatitis C virus: challenges and therapeutic advances. Insights from the Society of Infectious Diseases Pharmacists.
Deming P; McNicholl IR
Pharmacotherapy; 2011 Apr; 31(4):357-68. PubMed ID: 21449625
[TBL] [Abstract][Full Text] [Related]
12. What is killing people with hepatitis C virus infection?
Grebely J; Dore GJ
Semin Liver Dis; 2011 Nov; 31(4):331-9. PubMed ID: 22189973
[TBL] [Abstract][Full Text] [Related]
13. Focus on drug interactions: the challenge of treating hepatitis C virus infection with direct-acting antiviral drugs in the HIV-positive patient.
Rodríguez-Torres M
Curr Opin Infect Dis; 2013 Feb; 26(1):50-7. PubMed ID: 23242341
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology, responses, and way forward: the silent epidemic of viral hepatitis and HIV coinfection in Vietnam.
Sereno L; Mesquita F; Kato M; Jacka D; Nguyen TT; Nguyen TN
J Int Assoc Physicians AIDS Care (Chic); 2012; 11(5):311-20. PubMed ID: 22828983
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in a large population-based cohort.
Rossi C; Butt ZA; Wong S; Buxton JA; Islam N; Yu A; Darvishian M; Gilbert M; Wong J; Chapinal N; Binka M; Alvarez M; Tyndall MW; Krajden M; Janjua NZ;
J Hepatol; 2018 Nov; 69(5):1007-1014. PubMed ID: 30142429
[TBL] [Abstract][Full Text] [Related]
16. Safely treating hepatitis C in patients with HIV or hepatitis B virus coinfection.
Jafari A; Khalili H; Izadpanah M; Dashti-Khavidaki S
Expert Opin Drug Saf; 2015 May; 14(5):713-31. PubMed ID: 25813487
[TBL] [Abstract][Full Text] [Related]
17. [Coinfection with hepatitis C virus and HIV].
Ruys TA; Reesink HW; Lange JM
Ned Tijdschr Geneeskd; 2003 Oct; 147(42):2056-60. PubMed ID: 14606352
[TBL] [Abstract][Full Text] [Related]
18. HIV and HCV among people who inject drugs in Central Asia.
Walsh N; Maher L
Drug Alcohol Depend; 2013 Nov; 132 Suppl 1():S37-40. PubMed ID: 23906997
[TBL] [Abstract][Full Text] [Related]
19. Onsite treatment of HCV infection with direct acting antivirals within an opioid treatment program.
Butner JL; Gupta N; Fabian C; Henry S; Shi JM; Tetrault JM
J Subst Abuse Treat; 2017 Apr; 75():49-53. PubMed ID: 28237054
[TBL] [Abstract][Full Text] [Related]
20. Management of Hepatitis C/HIV Coinfection in the Era of Highly Effective Hepatitis C Virus Direct-Acting Antiviral Therapy.
Wyles DL; Sulkowski MS; Dieterich D
Clin Infect Dis; 2016 Jul; 63 Suppl 1(Suppl 1):S3-S11. PubMed ID: 27363438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
